Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 26 de abr. de 2024 · Type 1 diabetes (T1D) is a chronic condition in which beta cells are destroyed by immune cells. Despite progress in immunotherapies that could delay T1D onset, early detection of autoimmunity remains challenging. Here, we evaluate the utility of machine learning for early prediction of T1D using single-cell analysis of islets.

  2. 14 de may. de 2024 · Published May 14, 2024 in Beta cell replacement, Research. There’s a new approach to cell therapies for T1D being tested in human clinical trials—and JDRF deployed resources in many different ways to support it. Cell therapies are one of JDRF’s biggest priority areas.

  3. 16 de may. de 2024 · Abstract. Aim: To assess and verify the effect of the gut microbiome on the susceptibility and complications of type 1 diabetes (T1D). Materials and methods: To achieve this aim, a two-sample and reverse Mendelian randomization (MR) analysis was conducted.

  4. 28 de abr. de 2024 · Abstract. Autoimmune destruction of pancreatic β cells results in type 1 diabetes (T1D), with pancreatic immune infiltrate representing a key feature in this process. Studies of human T1D immunobiology have predominantly focused on circulating immune cells in the blood, while mouse models suggest diabetogenic lymphocytes primarily ...

  5. Hace 2 días · Type 1 diabetes (T1D), formerly known as juvenile diabetes, is an autoimmune disease that originates when cells that make insulin (beta cells) are destroyed by the immune system. Insulin is a hormone required for the cells to use blood sugar for energy and it helps regulate glucose levels in the bloodstream. [6]

    • Relatively short period of time
    • Blood sugar, A1C
  6. 17 de may. de 2024 · 0.25 CME. CE. ABIM MOC. 15 min. A 360-Degree Examination of Type 1 Diabetes: From Patient Identification to Treatment and Prevention. Learn how to identify those at risk for type 1 diabetes (T1D), how to stage T1D, and when and how to start interventions that can slow the progression of disease. 1.25 CME. CE. ABIM MOC. 75 min.

  7. 16 de may. de 2024 · The goal of this activity is for learners to be better able to screen for and stage T1D. Upon completion of this activity, participants will: Have increased knowledge regarding the. Recommendations for screening and staging pediatric patients at risk for T1D. Continued follow-up after diagnosis for patients with T1D.